Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Completed NCT07878260

Erectile and Ejaculatory Function Following Coronary Revascularization

Conditions: Erectile Dysfunction, Coronary Artery Disease, Ejaculation Disorders

Sex: Male
Ages: 18 Years – 80 Years
Healthy volunteers: Yes
Enrollment: 135
Sponsor: Saglik Bilimleri Universitesi

Location: Yenikent State Hospital Sakarya Adapazarı

Summary

This observational, cross-sectional study aims to compare erectile and ejaculatory function between men with a history of coronary revascularization and men without known coronary artery disease. The study included 135 adult male participants, including 66 men who had previously undergone percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and 69 men without known coronary artery disease. Erectile function was evaluated using the Sexual Health Inventory for Men (SHIM), premature ejaculation symptoms using the Premature Ejaculation Diagnostic Tool (PEDT), and ejaculatory function using the Male Sexual Health Questionnaire-Ejaculatory Dysfunction (MSHQ-EjD). Self-reported ejaculation latency was also assessed. The primary objective was to investigate the association between previous coronary revascularization and erectile function. Secondary objectives included comparing premature ejaculation symptoms, ejaculatory function, and ejaculation latency between the two groups.

Eligibility Criteria

Inclusion Criteria: * Adult male participants aged 18 years or older. * Attendance at cardiology or urology outpatient clinics. * Voluntary participation in the study. * For the coronary revascularization group: a history of percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) at least one month before questionnaire assessment. * For the comparison group: no known history of coronary artery disease, PCI, or CABG. Exclusion Criteria: * Patients receiving dialysis. * History of liver cirrhosis. * Left ventricular ejection fraction below 40%. * Coronary revascularization (PCI or CABG) within the preceding month.

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT07878260). StuddyBuddy aggregates publicly available trial information.